Regulatory Affairs
Navigating Regulatory Requirements Across International Markets.
Every pharmaceutical market has its own regulatory framework governing product registration, technical documentation and market authorisation.
At Ripharma Laboratories Ltd., our dedicated in-house regulatory team oversees:
- Regulatory coordination
- Dossier compilation
- Product registration requirements across our international markets
Our regulatory capabilities are further supported by collaboration with specialised technical consultants and qualified analytical laboratories. Where additional market-specific assessments, specialised analytical evaluations or advanced testing procedures are required, we coordinate access to the relevant expertise and technical infrastructure to address these requirements.
This integrated approach enables us to manage diverse regulatory requirements and support comprehensive product registration submissions across different jurisdictions.
Regulatory Capabilities
-
Regulatory Dossiers & Technical Documentation
Our in-house regulatory team facilitates the compilation, review and coordination of comprehensive pharmaceutical registration dossiers in accordance with applicable regulatory guidelines and country-specific submission requirements, in Common Technical Document (CTD) and ASEAN Common Technical Document (ACTD) formats, as applicable.
Dossier components encompass:
- Pharmaceutical product information
- Quality documentation
- Manufacturing details
- Specifications and analytical procedures
- Validation data
- Stability study reports
Together with other relevant technical information required for regulatory evaluation. Where applicable, supporting documentation may also include comparative dissolution data and other product-specific study reports required by the relevant regulatory authorities.
-
Specialised Technical Assessments & Analytical Requirements
Certain regulatory jurisdictions may require additional technical assessments, specialised analytical evaluations or supporting studies beyond the standard product registration documentation. Our in-house regulatory team coordinates these requirements in collaboration with:
- Specialised technical consultants
- Qualified analytical laboratories
Where additional assessments or testing are required beyond the available manufacturing and quality documentation, we facilitate access to the relevant technical expertise and specialised facilities to obtain the necessary evaluations, reports and supporting data in accordance with applicable regulatory guidelines.
Where bioequivalence studies are specifically mandated by the relevant regulatory authority, we can coordinate access to specialised study services and the associated supporting documentation through qualified external partners.
-
Product Certifications & Regulatory Documentation
We coordinate the requisite regulatory certificates and supporting documentation required for pharmaceutical product registration and international trade. Depending on the requirements of the importing country, these may include:
- Certificates of Pharmaceutical Product (CPP)
- GMP certificates
- Certificates of Analysis (COA)
- Manufacturing authorisations
- Other applicable regulatory documents
Documentation is aligned with the applicable regulatory framework and submission requirements of the respective markets.
-
Drug Master Files & API Documentation
Drug Master Files (DMFs) and associated Active Pharmaceutical Ingredient (API) documentation form an important part of pharmaceutical regulatory submissions. As required by the regulatory authority, we facilitate access to:
- Applicable DMFs
- API specifications
- Certificates of Analysis
- Manufacturing information
- Supporting quality documentation
The availability and scope of such documentation are subject to the relevant API manufacturer’s regulatory submissions and applicable confidentiality arrangements.
-
International Product Registration
We support the regulatory registration of pharmaceutical formulations across diverse international markets, taking into consideration the specific legislative, technical and administrative requirements of individual jurisdictions. Our regulatory activities include:
- Coordination of registration documentation and submission requirements
- Timely preparation and submission of responses to regulatory queries
- Compliance with product information and labelling requirements
- Subsequent regulatory updates, variations and renewals, as applicable
-
Regulatory Compliance & Lifecycle Management
Regulatory compliance extends beyond initial product registration. We recognise the importance of maintaining the regulatory status of pharmaceutical products through ongoing documentation management and attention to applicable post-registration requirements. This includes coordination of:
- Regulatory variations
- Renewals
- Updates to approved product information
- Other lifecycle documentation
All in accordance with the requirements of the respective regulatory authorities.
From Dossier To Market
Dossier Compilation
CTD and ACTD dossiers compiled to each market’s guidelines.
Certificates & Documentation
CPP, GMP certificates, COA and API documentation coordinated.
Submission & Queries
Registration submitted, and regulatory queries answered on time.
Lifecycle Management
Variations, renewals and product information kept current.
Our Regulatory Commitment
At Ripharma, our regulatory approach is centred on technical expertise, documentation integrity and adherence to applicable regulatory requirements.
By combining in-house regulatory capabilities with access to specialised external expertise, we remain committed to supporting compliant pharmaceutical product registrations and facilitating sustained access to international healthcare markets.